ARIDIS PHARMACEUTICALS INC ARDS
COM · Common Stock · CUSIP 040334104
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 17 |
| Q4 2022 | 18 |
| Q1 2023 | 21 |
| Q2 2023 | 19 |
| Q3 2023 | 1 |
| Q4 2023 | 2 |
| Q1 2024 | 0 |
| Q2 2024 | 0 |
| Q3 2024 | 0 |
| Q4 2024 | 0 |
| Q1 2025 | 0 |
| Q2 2025 | 0 |
| Q3 2025 | 1 |
| Q4 2025 | 0 |
| Q1 2026 | 1 |
| Q2 2026 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2023 | 8 | 8 |
| Q2 2023 | 8 | 6 |
| Q3 2023 | 0 | 18 |
| Q4 2023 | 2 | 1 |
| Q1 2024 | 0 | 1 |
| Q4 2025 | 0 | 1 |
| Q1 2026 | 1 | 0 |
| Q2 2026 | 0 | 0 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| ARMISTICE CAPITAL, LLC 13G · institution no change · filed 2026-08-14 | 11.4% |
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Strengthening Families & Communities, LLC 0.00% of their portfolio | 3.0k $0 | Unchanged |